Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cell adhesion molecule (CAM) interaction 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Cell adhesion molecule (CAM) interaction
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 2 | Epstein-Barr virus infection 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Epstein-Barr virus infection
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 3 | Human T-cell leukemia virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Human T-cell leukemia virus 1 infection
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 4 | IgSF CAM signaling 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬IgSF CAM signaling
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 5 | Integrin signaling 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Integrin signaling
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 6 | Leukocyte transendothelial migration 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Leukocyte transendothelial migration
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 7 | Malaria 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Malaria
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 8 | Natural killer cell mediated cytotoxicity 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Natural killer cell mediated cytotoxicity
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 9 | Neutrophil extracellular trap formation 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Neutrophil extracellular trap formation
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 10 | Rap1 signaling pathway 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Rap1 signaling pathway
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 11 | Regulation of actin cytoskeleton 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Regulation of actin cytoskeleton
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 12 | Rheumatoid arthritis 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Rheumatoid arthritis
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 13 | Staphylococcus aureus infection 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Staphylococcus aureus infection
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||
| 14 | Viral myocarditis 💬 1 gene, 1 drug (DrugBank) and 10 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecule (CAM) interaction
|
Efalizumab Efalizumab 💬Viral myocarditis
| Efalizumab | 011 [10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬1. Cell adhesion molecule (CAM) interaction
|
Cell adhesion molecule (CAM) interaction
1 gene, 1 drug (DrugBank) and 10 diseases
Epstein-Barr virus infection
1 gene, 1 drug (DrugBank) and 10 diseases
Human T-cell leukemia virus 1 infection
1 gene, 1 drug (DrugBank) and 10 diseases
IgSF CAM signaling
1 gene, 1 drug (DrugBank) and 10 diseases
Integrin signaling
1 gene, 1 drug (DrugBank) and 10 diseases
Leukocyte transendothelial migration
1 gene, 1 drug (DrugBank) and 10 diseases
Malaria
1 gene, 1 drug (DrugBank) and 10 diseases
Natural killer cell mediated cytotoxicity
1 gene, 1 drug (DrugBank) and 10 diseases
Neutrophil extracellular trap formation
1 gene, 1 drug (DrugBank) and 10 diseases
Rap1 signaling pathway
1 gene, 1 drug (DrugBank) and 10 diseases
Regulation of actin cytoskeleton
1 gene, 1 drug (DrugBank) and 10 diseases
Rheumatoid arthritis
1 gene, 1 drug (DrugBank) and 10 diseases
Staphylococcus aureus infection
1 gene, 1 drug (DrugBank) and 10 diseases
Viral myocarditis
1 gene, 1 drug (DrugBank) and 10 diseases
